Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

View:
Post by ENEMENEMYNEMO on Sep 19, 2024 12:37pm

NR

What an absolute shite NR!!!!!

Great results embedded in there but to the average investor it would read negative. 

F'n disaster...

Comment by ENEMENEMYNEMO on Sep 19, 2024 12:45pm
Dumping my shares currently.  See ya'll at .50 cents...take care Azzzcrack and Canadafan...I know you will still be here then suckas'
Comment by Azzak34 on Sep 19, 2024 1:36pm
Haha what a clown. Did you really say normal people won't understand the great results we just posted because of the wording?  You don't have any shares and I doubt you've ever had any. And dumping on this news is why you'll never make any money investing. 
Comment by Peladawn on Sep 19, 2024 1:36pm
Ok.....bye!......good riddance, meathead!
Comment by spesestsemper on Sep 19, 2024 1:40pm
I have to agree that the news release is horribly written . All people see is that median os was not reached . If they don't read the NR carefully , they don't see this is a good thing . Hardly think this positive NR justifies selling but each their own . I know one thing this isnt the important NR . The next one will be , how the funding is done . If it is a private placement at these ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities